CAS: 43088-42-2; Ethyl 2-Amino-4-Methylthiophene-3-Carboxylate

该化合物是具有硫环结构特征的有机化合物,是五人组成的芳香异环,含有硫磺,该化合物具有乙酯功能组,氨基组和硫苯环的甲基替代成分,具有独特的化学特性,通常是室温固体,由于氨基和氨基蛋白类的存在,极地有机溶剂中表现出中等溶解性.乙基-2-氨基-4-甲基硫苯-3-碳本甲酸酯对各个领域都感兴趣,包括药用化学学,可以作为合成生物活性化合物的建筑块.其活性可能受到亚芬子组对硫环的电温和电镀效应的影响,因此在有机合成中可以显示其具有多功能性中间体.应参考乙基-2-氨基甲基-甲基苯三-氯本基甲酸酯数据,用于处理和储存,作为所有化学物质.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号105-56-6 氰乙酸乙酯 | CAS号67-64-1 丙酮 | CAS号109-89-7 二乙胺 | CAS号43088-64-8 5-甲基-3,4-二氢噻吩并[... | CAS号51486-14-7 2-mercapto-3,5-...

合成工艺路线路线简述

  • 合成目标产物 Ethyl 2-Amino-4-Methylthiophene-3-Carboxylate 主要起始原料 Ethyl Cyanoacetate And Acetone
  • (文献来源)合成步骤主要原料 Ethyl Cyanoacetate 和 Acetone
Ethyl 2-Amino-4-Methyl-5-(Tert-Butoxycarbonyl)Thiophene-3-Carboxylate置于盐酸体系中,用 乙醇 作为反应溶剂,化学反应 1.0H,以85%的收率获得产物2-氨基-4-甲基-噻吩-3-羧酸乙酯
参考文献:2-(Diethylamino)Thieno[1,3]Oxazin-4-Ones As Stable Inhibitors Of Human Leukocyte Elastase
标题:2-(Diethylamino)Thieno[1,3]Oxazin-4-Ones As Stable Inhibitors Of Human Leukocyte Elastase
摘要:A Series Of 2-(Diethylamino)Thieno[1,3]Oxazin-4-Ones Was Synthesized And Evaluated In Vitro For Inhibitory Activity Toward Human Leukocyte Elastase (Hle). The Gewald Thiophene Synthesis Was Utilized To Obtain Several Ethyl 2-Aminothiophene-3-Carboxylates. These Precursors Were Subjected To A Five-Step Route To Obtain Thieno[2,3-D][1,3]Oxazin-4-Ones Bearing Various Substituents At Positions 5 And 6. Both Thieno[2,3-D] And Thieno[3,2-D] Fused Oxazin-4-Ones Possess Extraordinary Chemical Stability,Which Was Expressed As Rate Constants Of The Alkaline Hydrolysis. The Kinetic Parameters Of The Hle Inhibition Were Determined. The Most Potent Compound,2-(Diethylamino)-4H-[1]Benzothieno[2,3-D][1,3]Oxazin-4-One,Exhibited A K-I Value Of 5.8 Nm. 2-(Diethylamino)Thieno[1,3]Oxazin-4-Ones Act As Acyl-Enzyme Inhibitors Of Hle,Similar To The Inhibition Of Serine Proteases By 4H-3,1-Benzoxazin-4-Ones. The Isosteric Benzene-Thiophene Replacement Accounts For An Enhanced Stability Of The Acyl-Enzyme Intermediates.
DOI:10.1021/jm991108W

海关参考信息

专利信息


专利号:US-4670560-A
优先权日:1986-04-28
标 题:Thienopyrimidine-2,4-dione derivatives and intermediates thereof
发明人:PRESS JEFFERY B; RUSSELL RONALD K
权利人:ORTHO PHARMA CORP
摘要:The synthesis of thienopyrimidine-2,4-dione derivatives and their urea intermediates is described. The novel urea intermediates and thienopyrimidine-2,4-dione derivatives are generally vasodilating agents and anti-hypertensive agents. The compounds are useful as cardiovascular agents.

专利号:US-4707550-A
优先权日:1986-04-28
标题 :N-(substituted thienyl)-N'-(substituted piperazinyl)-ureas
发明人:PRESS JEFFERY B; RUSSELL RONALD K
权利人:ORTHO PHARMA CORP
摘要:The synthesis of thienopyrimidine-2,4-dione derivatives and their urea intermediates is described. The novel urea intermediates and thienopyrimidine-2,4-dione derivatives are general vasodilating agents and anti-hypertensive agents. The compounds are useful as cardiovascular agents.

专利号:US-7030240-B2
优先权日:2003-03-31
标 题:Piperidinylamino-thieno[2,3-d] pyrimidine compounds
发明人:DHANOA DALE S; BECKER OREN; NOIMAN SILVIA; REDDY SEKAR A; CHERUKU SRINIVASA RAO; MELE NDEZ ROSA E; SHARADENDU ANURAG; CHEN DONGLI; MARANTZ YAEL; SHACHEM SHARON; HEIFETZ ALEXANDER; INBAL BOAZ; KESAVAN VENKITASAMY; BAR-HAIM SHAY
权利人:PREDIX PHARMACEUTICALS HOLDING
摘要:The invention relates to 5-HT receptor antagonists. Novel piperidinylamino-thieno[2,3-d] pyrimidine compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include central nervous system disorders such as anxiety, depression, schizophrenia, neural injury, stroke, and migraine. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.
常州环灵化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.huanlingchem.com
电话: 0519-89803565 13776850645👤
📞常州环灵化工有限公司 ⚠️参考联系方式

销售电话:0519-89803565 13776850645
邮箱:info4@huanlingchem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1177/1087057116635503
摘要:Voter AF, Manthei KA, Keck JL. A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. J Biomol Screen. 2016 Jul;21(6):626–33.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知